Skip to content
TrackPodcasts
businessApr 15, 202650:14failed

Gaurav Aggarwal, Managing Partner, Vivo Capital "Breaking Into—and Leading—Life Sciences Investing"

AAAIM High ELI

About this episode

Our guest for today's podcast is Dr. Gaurav Aggarwal.  Dr. Aggarwal is a Managing Partner at Vivo Capital, a global healthcare specialist with a multi-strategy investment platform covering venture capital, private equity, and public equity strategies. The firm seeks to support the expansion of healthcare access via investments in the industry, and to catalyze innovation and growth via its "Ecosystem Strategy."

Dr. Aggarwal and has invested in the life sciences sector for over 25 years including almost 10 years at Vivo Capital at the time of this recording.  Prior to Vivo, Dr. Aggarwal was Chief Business Officer of Ocera Therapeutics, a publicly traded clinical-stage company, prior to which he served as a General Partner at Panorama Capital. He began his career in private equity at JPMorgan Partners. Dr. Aggarwal currently serves on the board of Unicycive Therapeutics and on the boards of several private companies across the medical device, pharmaceutical services and biopharmaceutical sectors.

Dr. Aggarwal received his M.D. from Columbia University, College of Physicians & Surgeons and his B.S. in Agricultural Economics from Cornell University.

Without further ado, here is our conversation with Gaurav Aggarwal.

Get every episode summarized

Each time AAAIM High ELI publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

Gaurav Aggarwal, Managing Partner, Vivo Capital "Breaking Into—and Leading—Life Sciences Investing"

AAAIM High ELI

0:00
50:14

More episodes

More from AAAIM High ELI

View all episodes →